Company profile: Crucell
1.1 - Company Overview
Company description
- Provider of global biopharmaceutical vaccine development.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Crucell
Cytovale
HQ: United States
Website
- Description: Provider of early detection diagnostic technologies for immune-mediated diseases, including the IntelliSep Test for rapid sepsis identification with results in under 10 minutes to aid emergency department triage, powered by microfluidics, precision imaging, and machine learning to analyze complex biological data and perform detailed cellular analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cytovale company profile →
Ausper Bio
HQ: China
Website
- Description: Provider of biotechnology therapies developing ASO and oligonucleotide-conjugate drugs for chronic hepatitis B and other major infectious diseases, featuring AHB-137 (Phase I) targeting a conserved HBV mRNA region with potential HBsAg reduction and favorable safety, and Med-Oligo platforms that enhance ASO potency and safety, combining small molecule and antibody expertise.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ausper Bio company profile →
Lumos Diagnostics
HQ: United States
Website
- Description: Provider of rapid point-of-care diagnostic solutions, including customized assay development, full-scale contract manufacturing for lateral flow strips and readers, proprietary digital reader platforms, companion apps, and cloud connectivity for data capture and visualization, supported by in-house clinical study design, site management, and regulatory affairs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lumos Diagnostics company profile →
Clever Culture Systems
HQ: Switzerland
Website
- Description: Provider of intelligent image analysis solutions using artificial intelligence, including APAS Independence for automated microbial environmental monitoring with digital records, audit trails, standardized workflows and reduced human error, and MRSA and VRE Analysis Modules that automate detection on chromogenic media for efficient infection control by reporting negatives and triaging positives for review.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clever Culture Systems company profile →
Mucosis
HQ: The Netherlands
Website
- Description: Provider of clinical-stage mucosal vaccines delivered needle-free via the nose or mouth, including SynGEM®, an intranasal vaccine candidate to prevent respiratory syncytial virus infection.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mucosis company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Crucell
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Crucell
2.2 - Growth funds investing in similar companies to Crucell
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Crucell
4.2 - Public trading comparable groups for Crucell
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →